Riskpilot← Back to searchSign inGet full accessBERGH-INVEST AS
ASActiveOrg 989025937Frydenlundgata 19, 8517 NarvikRetail sale of medical and orthopaedic goods · NACE 4774Est. 20060 employees
Revenue 2024
NOK 222K
0% vs 2023
EBITDA margin
76.3%
0% vs 2023
Equity ratio
52.6%
Financial strength
Net profit 2024
NOK 912K
+11% vs 2023
| Revenue | NOK 222K | +0% |
| EBITDA | NOK 169K | +0% |
| Net profit | NOK 912K | +11% |
| Total assets | NOK 15,3M | -4% |
| Equity | NOK 8M | +9% |
| Employees | 0 | — |
Legal name
BERGH-INVEST AS
Org number
989025937
Legal form
Aksjeselskap
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
24. januar 2006
Share capital
NOK 320 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Investering i andre selskap med økonomisk formål.
Address
Frydenlundgata 19, 8517 Narvik
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 184 | 222 | 222 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −90 | −97 | 94 | 169 | 169 |
| Depreciation & amort. | −0 | −82 | −82 | −82 | −82 |
| EBIT | −90 | −179 | 12 | 87 | 87 |
| Net financials | 445 | 1 019 | 1 025 | 760 | 850 |
| Profit before tax | 354 | 839 | 1 036 | 847 | 937 |
| Tax | −0 | −0 | 30 | 23 | 26 |
| Net profit | 354 | 839 | 1 006 | 824 | 912 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 9 674 | 9 605 | 8 667 | 15 859 | 15 291 |
| Equity | 4 699 | 5 538 | 6 544 | 7 368 | 8 045 |
| Long-term debt | 0 | 3 955 | 1 925 | 8 261 | 6 453 |
| Short-term debt | 4 975 | 112 | 197 | 230 | 794 |
| Total debt | 4 975 | 4 067 | 2 122 | 8 491 | 7 246 |
EBITDA margin
76.3%
This company
15.8%
Market median
+383% vs market
20202024
Equity ratio
52.6%
This company
38.2%
Market median
+38% vs market
20202024
Return on equity
11.3%
This company
18.4%
Market median
+39% vs market
20202024
Net profit margin
410.6%
This company
8.1%
Market median
+4969% vs market
20202024
Asset turnover
0.01×
This company
1.12×
Market median
-99% vs market
20202024
Debt / equity
0.90×
This company
0.62×
Market median
+45% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2021 | |
| Former (3) | ||
| Board of Directors | 2006 – 2021 | |
| Board of Directors | 2006 – 2021 | |
| Board of Directors | 2006 – 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
BERGH-INVEST AS 
BRILLEHUSET OPTIKER EGIL BERGH ASBoard members of BERGH-INVEST AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Einar Bergh | Board of Directors | 0 companies |
| Anita Karin Bergh | Board of Directors | 0 companies |
| Egil Bergh | Chairman | 0 companies |
| Stian Bergh | Board of Directors | 0 companies |